Glutamate: A role in normal brain function, anaesthesia, analgesia and CNS injury

British Journal of Anaesthesia

Volumn 78, Issue 6, 1997, Pages 731-747

  Hudspith, M J ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Anaesthesia, general; Brain, glutamate; Nerve, neurotransmitters; Pain; Protein, amino acids, glutamate

Indexed keywords

AMINO ACID RECEPTOR; ANESTHETIC AGENT; EXCITATORY AMINO ACID; GLUTAMIC ACID; NEUROPROTECTIVE AGENT;

ANALGESIA; ANESTHESIA; BRAIN FUNCTION; CENTRAL NERVOUS SYSTEM; GENERAL ANESTHESIA; LEARNING; MEMORY; NERVOUS SYSTEM INJURY; NEUROTOXICITY; NEUROTRANSMISSION; PAIN; PRIORITY JOURNAL; RECALL; REVIEW; SYNAPTOSOME;

EID: 0030983492     PISSN: 00070912     EISSN: None     Source Type: Journal    
DOI: 10.1093/bja/78.6.731     Document Type: Review

References (232)

1. Abram SE, Yaksh TL. Morphine, but not inhalational anesthesia blocks post-injury facilitation. Anesthesiology 1993; 78: 713-721.
2. Alford S, Brodin L. The role of NMDA receptors in synaptic integration and the organization of motor function. In: Collingridge GL, Watkins JC, eds. The NMDA receptor, 2nd Edn. Oxford: Oxford University Press, 1994; 277-293.
3. Angel A. Adventures in anaesthesia. Experimental Physiology 1991; 76: 1-38.
4. Antognini JF, Schwartz K. Exaggerated anesthetic requirements in the preferentially anesthetized brain. Anesthesiology 1993; 79: 1244-1249.
5. 3H]D-aspartate from rat brain slices. Acta Anaesthesiologica Scandinavica 1990; 34: 267-270.
6. Arendt-Nielsen L, Petersen-Felix S, Fischer M, Bak P, Bjerring P, Zbinden AM. The effect of N-methyl-D-aspartate antagonist (ketamine) on single and repeated nociceptive stimuli: a placebo controlled experimental human study. Anesthesia and Analgesia 1995; 81: 63-68.
7. 45Ca uptake by rat brain microvesicles. Neurochemical Research 1994; 19: 1515-1520.
8. Artola A, Singer W. Long term potentiation and NMDA receptors in rat visual cortex. Nature (London) 1987; 330: 649-652.
9. Ashton H. Brain Function and Psychotropic Drugs. Oxford: Oxford University Press, 1992; 154-157.
10. Backonja M, Arndt G, Gombar KA, Check B, Zimmerman M. Response of chronic neuropathic pain syndromes to ketamine: a preliminary study. Pain 1994; 56: 51-57.
11. Baker AJ, Moulton RJ, MacMillan VH, Shedden PM. Excitatory amino acids in cerebrospinal fluid following traumatic brain injury in humans. Journal of Neurosurgery 1993; 79: 369-372.
12. Beneveniste H, Drejer J, Schousboe A, Diemer H. Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischaemia monitored by intracerebral microdialysis. Journal of Neurochemistry 1984; 43: 1369-1374.
13. Berg-Johnsen J, Langmoen IA. The effect of isoflurane on excitatory synaptic transmission in the rat hippocampus. Acta Anaesthesiologica Scandinavica 1992; 36: 350-355.
14. Bertlik M, Orser BA, Lu-Wang Y, MacDonald JF. Propofol selectively inhibits the NMDA subtype of glutamate receptor. Canadian Journal of Anaesthesia 1994; 41: A6.
15. Bianchi M, Battistin T, Galzigna L. 2,6-Diisopropyl phenol, a general anesthetic inhibits glutamate action in rat synaptosomes. Neurochemical Research 1991; 16: 443-446.
16. Bickler PE, Buck LT, Hansen BM. Effects of isoflurane and hypothermia on glutamate receptor-mediated calcium influx in brain slices. Anesthesiology 1994; 81: 1461-1469.
17. Bindman LJ, Murphy KPSJ, Pockett S. Postsynaptic control of the induction of long term changes in efficacy of transmission in neocortical slices of rat brain. Journal of Neurophysiology 1988; 60: 1053-1065.
18. Bion JF. Intrathecal ketamine for war surgery: a preliminary study under field conditions. Anaesthesia 1984; 39: 1023-1028.
19. Bliss TVP, Collingridge GL. A synaptic model of memory: long term potentiation in the hippocampus. Nature (London) 1993; 361: 31-39.
20. Bliss TVP, Lømo TJ. Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path. Journal of Physiology (London) 1973; 232: 331-356.
21. Borbjerg FM, Svensson BA, Frigast C, Gordh T. Histopathology after repeated intrathecal injections of preservative-free ketamine: a light and electron microscope examination. Anesthesia and Analgesia 1994; 79: 105-111.
22. Borges M, Antognini JF. Does brain influence somatic responses to noxious stimuli during isoflurane anesthesia? Anesthesiology 1994; 81: 1511-1515.
23. Broadley KE, Kurowska A, Tookman A. Ketamine injection used orally. Palliative Medicine 1996; 10: 247-250.
24. Carla V, Moroni F. General anaesthetics inhibit the responses induced by glutamate receptor agonists in the mouse cortex. Neuroscience Letters 1992; 146: 21-24.
25. Chen H-SV, Pellegrini JW, Aggarwal SK, Lei SZ, Warach S, Jensen FE, Lipton SA. Open channel block of N-methyl-D-aspartate (NMDA) responses by memantine: therapeutic advantage against NMDA receptor-mediated neurotoxicity. Journal of Neuroscience 1992; 12: 4427-4436.
26. 2+ block of NMDA-receptor channels as a mechanism of modulation. Nature (London) 1992; 356: 521-523.
27. Choi DW. Dextrorphan and dextromethorphan attenuate glutmate neurotoxicity. Brain Research 1987; 403: 333-336.
28. Church J. Neuromodulatory effects of dextromethorphan: role of NMDA receptors in responses. Trends in Pharmacological Sciences 1990; 11: 146-147.
29. Coderre TJ. Potent analgesia induced in rats by combined action at PCP and polyamine recognition sites. European Journal of Neuroscience 1993; 5: 390-393.
30. Coderre TJ, Katz J, Vaccarino A, Melzack R. Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence. Pain 1993; 52: 259-285.
31. Coderre TJ, Van Empel I. The utility of excitatory amino acid (EAA) antagonists as analgesic agents. I. Comparison of the antinociceptive activity of various classes of EAA antagonists in mechanical thermal and chemical nociceptive tests. Pain 1994; 59: 345-352.
32. Coderre TJ, Van Empel I. The utility of excitatory amino acid (EAA) antagonists as analgesic agents. II. Assessment of the antinociceptive activity of combinations of competitive and non-competitive NMDA antagonists with agents acting at allosteric-glycine and polyamine receptor sites. Pain 1994; 59: 353-359.
33. Collins CGS. Release of endogenous amino acid neurotransmitter candidates from rat olfactory cortex slices: possible regulatory mechanisms and the effects of pentobarbitone. Brain Research 1980; 190: 517-523.
34. Collins JG, Kendig JJ, Mason P. Anaesthetic ations within the spinal cord: contributions to the state of general anaesthesia. Trends in Neurosciences 1995; 18: 549-553.
35. Corssen G, Miyasaka M, Domino EF. Changing concepts in pain control during surgery: dissociative anesthesia with CI-581: a progress report. Anesthesia and Analgesia, Current Researches 1968; 47: 746-759.
36. Cotman CW, Monaghan DT, Storm-Mathisen J. Anatomical organization of excitatory amino acid receptors and their pathways. Trends in Neurosciences 1987; 10: 273-280.
37. Crosby G, Crane AM, Solokoff L. Local changes in cerebral glucose utilization during ketamine anesthesia. Anesthesiology 1982; 56: 437-443.
38. Dam M, Ori C, Pizzolato G, Richierri CL, Pellegrini, A, Giorn GP, Battistin L. The effect of propofol on local cerebral glucose utilization in the rat. Anesthesiology 1990; 73: 499-505.
39. Daniell LC. The non-competitive N-methyl-D-aspartate antagonists, MK-801, phencyclidine and ketamine increase the potency of general anesthetics. Pharmacology, Biochemistry and Behaviour 1990; 36: 111-115.
40. Daniell LC. Effects of CGS 19755, a competitive N-methyl-D-aspartate receptor antagonist on general anesthetic potency. Pharmacology, Biochemistry and Behavior 1991; 40: 767-769.
41. Daniell LC. Alterations in general anesthetic potency by agonists and antagonists of the polyamine site of the N-methyl-D-aspartate receptor. Journal of Pharmacology and Experimental Therapeutics 1992; 261: 304-310.
42. Davis DW, Hawkins RA, Mans AM, Hibbard LS, Biebuyck JF. Regional cerebral glucose utilization during Althesin anesthesia. Anesthesiology 1984; 61: 362-368.
43. Davis DW, Mans AM, Biebuyck JF, Hawkins RA. Regional cerebral glucose utilization in rats during etomidate anesthesia. Anesthesiology 1986; 64: 751-757.
44. Davis DW, Mans AM, Biebuyck JF, Hawkins RA. The influence of ketamine on regional brain glucose use. Anesthesiology 1988; 69: 199-205.
45. 3) pituitary cells. Anesthesiology 1994; 80: 1379-1389.
46. Dickenson AH. Mechanisms of the analgesic actions of opiates and opioids. British Medical Bulletin 1991; 47: 690-702.
47. Dickenson AH. Recent advances in the physiology and pharmacology of pain: plasticity and its implications for clinical analgesia. Journal of Psychopharmacology 1991; 5: 342-351.
48. Dickenson AH. Spinal cord pharmacology of pain. British Journal of Anaesthesia 1995; 75: 193-200.
49. Dickenson AH, Aydar E. Antagonism at the glycine site on the NMDA receptor reduces spinal nociception in the rat. Neuroscience Letters 1991; 121: 263-266.
50. Dildy-Mayfield JE, Eger EI II, Harris RA. Anesthetics produce subunit-selective actions on glutamate receptors. Journal of Pharmacology and Experimental Therapeutics 1996; 276: 1058-1065.
51. Donevan SD, Rogawski MA. GYKI 52466, a 2,3 benzodiazepine, is a highly selective, non-competitive antagonist of AMPA/kainate-receptor responses. Neuron 1993; 10: 51-59.
52. Dray A, Urban L, Dickenson A. Pharmacology of chronic pain. Trends in Pharmacological Sciences 1994; 15: 190-197.
53. Dunbar S, Yaksh TL. Concurrent infusion of MK801 blocks spinal tolerance and dependence induced by chronic intrathecal morphine in the rat. Anesthesiology 1996; 84: 1177-1188.
54. Dundee JW. After thiopentone: a review of recent history. Baillière's Clinical Anaesthesiology 1991; 5: 267-281.
55. 2+ channels in mammalian central neurones. Trends in Neurosciences 1995; 18: 89-98.
56. Durand G, Bennett MVL, Zukin RS. Splice variants of the N-methyl-D-aspartate receptor NR1 identify domains involved in regulation by polyamines and protein kinase C. Proceedings of the National Academy of Sciences USA 1993; 90: 6731-6735.
57. Dwyer R, Bennett HL, Eger EI II, Heilbron D. Effects of isoflurane and nitrous oxide in subanesthetic concentrations on memory and responsiveness in volunteers. Anesthesiology 1992; 77: 888-898.
58. Edwards FA. LTP - A structural model to explain the inconsistencies. Trends in Neurosciences 1995; 18: 250-255.
59. Eide PK, Jorum E, Stubhaug A, Bremnes J, Breivik H. Relief of post-herpetic neuralgia with the N-methyl-D-aspartic acid receptor antagonist ketamine, cross-over comparison with morphine and placebo. Pain 1994; 58: 347-354.
60. Eilers H, Bickler PE. Hypothermia and isoflurane similarly inhibit glutamate release evoked by chemical anoxia in rat cortical brain slices. Anesthesiology 1996; 85: 600-607.
61. Eisenberg E, Vos BP, Strassman AM. The NMDA antagonist memantine blocks pain behaviour in a rat model of formalin-induced facial pain. Pain 1993; 54: 301-307.
62. Faden AI, Demediuk P, Panter SS, Vink R. The role of excitatory amino acids and NMDA receptors in traumatic brain injury. Science 1989; 244: 798-800.
63. Faden AI, Salzman S. Pharmacological strategies in CNS trauma. Trends in Pharmacological Sciences 1992; 13: 29-35.
64. Fairman W, Vandenberg RJ, Arriza JL, Kavanaugh MP, Amara SG. An excitatory amino acid transporter with the properties of a ligand-gated chloride channel. Nature (London) 1995; 375: 599-603.
65. Finck AD, Samaniego E, Ngai SH. Nitrous oxide selectively releases Met5-enkephalin and Met5-enkephalin-Arg6-Phe7 into canine third ventricular cerebrospinal fluid. Anesthesia and Analgesia 1995; 80: 664-670.
66. Flohr H. An information processing theory of anaesthesia. Neuropsychologia 1995; 33: 1169-1180.
67. Franks NP, Lieb WR. Molecular and cellular mechanism of general anaesthesia. Nature (London) 1994; 367: 607-614.
68. Ghoneim M, Block RI. Learning and consciousness during general anesthesia. Anesthesia 1992; 76: 279-305.
69. Ghoneim MM, Hinrichs JV, Mewaldt J, Petersen RC. Ketamine: behavioral effects of subanesthetic doses. Journal of Clinical Psychophannacology 1985; 5: 70-77.
70. Gogas KR, Cho HJ, Botchkina GI, Levine JD, Basbaum AI. Inhibition of noxious stimulus-evoked pain behaviors and neuronal fos-like immunoreactiviry in the spinal cord of the rat by supraspinal morphine. Pain 1996; 65: 9-15.
71. Goldman RS, Finkbeiner SM. Therapeutic uses of magnesium sulfate in selected cases of cerebral ischemia and seizure. New England Journal of Medicine 1988; 319: 1224-1225.
72. Goto T, Marota JJA, Crosby G. Nitrous oxide induces preemptive analgesia in the rat that is antagonized by halothane. Anesthesiology 1994; 80: 409-416.
73. Gozlan H, Ben-Ari Y. NMDA receptor redox sites: are they targets for selective neuronal protection? Trends in Pharmacological Sciences 1995; 16: 368-374.
74. 2 adrenergic receptors in the rat. Anesthesiology 1996; 85: 846-852.
75. Haley JE, Sullivan AF, Dickenson AH. Evidence for spinal N-methyl-D-aspartate receptor involvement in chemical nociception in the rat. Brain Research 1990; 518: 218-226.
76. Hall AC, Lieb WR, Franks NP. Insensitivity of P-type calcium channels to inhalational and intravenous general anesthetics. Anesthesiology 1994; 81: 117-125.
77. Hawkins RA, Biebuyck JF. Regional brain function during graded halothane anesthesia. In: Fink BR, ed. Molecular Mechanisms of Anesthesia. New York: Raven Press, 1980; 145-156.
78. Headley PM, Grillner S. Excitatory amino acids and synaptic transmission: the evidence for a physiological function. Trends in Pharmacological Sciences 1990; 11: 205-211.
79. Hirose T, Inoue M, Uchida M, Inagaki C. Enflurane-induced release of the excitatory amino acid glutamate. Anesthesiology 1992; 77: 109-113.
80. Hodes JE, Soncrant TT, Larson DM, Carlson SG, Rapoport SI. Selective changes in local cerebral glucose utilization induced by phenobarbital in the rat. Anesthesiology 1985; 63: 633-639.
81. 2+ permeability of KA-AMPA-gated glutamate receptor channels depends on subunit composition. Science 1991; 252: 1028-1031.
82. Huettner JE. Glutamate receptor channels in rat DRG neurons: activation by kainate and quisqualate and blockade of desensitization by Con A. Neuron 1990; 5: 255-266.
83. Huntley GW, Vickers JC, Morrison JH. Cellular and subcellular localization of NMDA and non-NMDA receptor subunits in neocortex: organizational features related to circuitry, function and disease. Trends in Neurosciences 1994; 17: 536-543.
84. Illievich UM, Zornow MH, Choi KT, Scheller MS, Strnat MAP. Effects of hypothermic metabolic suppression on hippocampal glutamate concentrations after transient global cerebral ischemia. Anesthesia and Analgesia 1994; 78: 905-911.
85. Islas J-A, Astorga J, Laredo M. Epidural ketamine for control of postoperative pain. Anesthesia and Analgesia 1985; 64: 1161-1162.
86. IUPHAR. Excitatory amino acid receptors (ionotropic). In: TiPS Receptor and Ion Channel Nomenclature Supplement, 7th Edn. Cambridge: Elsevier Science, 1996; 32.
87. IUPHAR. Excitatory amino acid receptors (metabotropic). In: TiPS Receptor and Ion Channel Nomenclature Supplement, 7th Edn. Cambridge: Elsevier Science, 1996; 33-34.
88. Iversen LL. Uptake processes for biogenic amines. In: Iversen LL, ed. Handbook of Psychopharmacology. New York: Plenum Publishing, 1975; 381-442.
89. Iversen LL, Kemp JA. Non-competitive NMDA antagonists as drugs. In: Collingridge GL, Watkins JC, eds. The NMDA receptor, 2nd Edn. Oxford: Oxford University Press, 1994; 469-486.
90. Izquierdo I. Role of NMDA receptors in memory. Trends in Pharmacological Sciences 1991; 12: 128-129.
91. 3H]kainic acid binding sites. Neuroscience 1989; 32: 587-607.
92. 3H]MK-801 binding: evidence for access to closed and open N-methyl-D-aspartate receptor channels. Molecular Pharmacology 1989; 35: 387-393.
93. Johnson JW, Ascher P. Glycine potentiates the NMDA response in cultured mouse brain neurones. Nature (London) 1987; 325: 529-531.
94. Jones JG, Munglani R. Monitoring depth of anaesthesia. In: Sebel PS, Fitch W, eds. Monitoring: The Central Nervous System. Oxford: Blackwell Scientific, 1994; 181-221.
95. 2-adrenoceptors inhibit glutamate release from rat spinal cord synaptosomes. Journal of Neurochemistry 1993; 60: 522-526.
96. Kanai Y, Hediger MA. Primary structure and functional characterization of a high affinity glutamate transporter. Nature (London) 1992; 360: 467-471.
97. Kangrga I, Randic M. Outflow of endogenous aspartate and glutamate from the rat spinal dorsal horn in vitro by activation of low and high threshold primary afferent fibres. Brain Research 1991; 553: 347-352.
98. Katayama Y, Becker DP, Tamura T, Hovda D. Massive increases in extracellular potassium and the indiscriminate release of glutamate following concussive brain injury. Journal of Neurosurgery 1990; 73: 889-900.
99. Kawana Y, Sato H, Shimada H, Fujita N, Ueda Y, Hayashi A, Araki Y. Epidural ketamine for postoperative pain relief after gynecologic operations: a double blind study and comparison with epidural morphine. Anesthesia and Analgesia 1987; 66: 735-738.
100. Kendall TJG, Minchin MCW. The effect of anaesthetics on the uptake and release of amino acid transmitters in thalamic slices. British Journal of Pharmacology 1982; 75: 219-227.
101. Kendig JJ, MacIver MB, Roth SH. Anesthetic actions in the hippocampal formation. Annals of the New York Academy of Sciences 1991; 625: 37-53.
102. Kress HG. Effects of general anaesthetics on second messenger systems. European Journal of Anaesthesiology 1995; 12: 83-97.
103. Kristensen JD, Karlsten R, Gordh T. Laser-Doppler evaluation of spinal cord blood flow after intrathecal administration of N-methyl-D-aspartate antagonist in rats. Anesthesia and Analgesia 1994; 78: 925-931.
104. Kristensen JD, Karlsten R, Gordh T, Berge O-G. The NMDA antagonist 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid (CPP) has antinociceptive effect after intrathecal injection in the rat Pain 1994; 56: 59-67.
105. Kristensen JD, Post C, Gordh T, Svensson BA. Spinal cord morphology and antinociception after chronic intrathecal administration of excitatory amino acid antagonists in the rat. Pain 1993; 54: 309-316.
106. Krnjevic K, Puil E. Halothane suppresses slow inward current in hippocampal slices. Canadian Journal of Physiology and Pharmacology 1988; 66: 1570-1575.
107. Kuroda Y, Strebel S, Rafferty C, Bullock R. Neuroprotective doses of N-methyl-D-aspartate receptor antagonists profoundly reduce the minimum anesthetic concentration (MAC) for isoflurane in rats. Anesthesia and Analgesia 1993; 77: 795-800.
108. Langmoen IA, Larsen M, Berg-Johnsen J. Volatile anaesthetics: cellular mechanisms of action. European Journal of Anaesthesiology 1995; 12: 51-58.
109. 2+-dependent glutamate release from rat cerebral cortex. Brain Research 1994; 663: 335-337.
110. Lei SZ, Pan ZH, Aggarwal SK, Chen H-SV, Hartman J, Sucher NJ, Lipton SA. Effect of nitric oxide production on the redox modulatory site on the NMDA receptor-channel complex. Neuron 1992; 8: 1087-1099.
111. Lemke M, Yum SW, Faden AI. Lipid alterations correlate with tissue magnesium decrease following impact trauma in rabbit spinal cord. Molecular and Chemical Neuropathology 1990; 12: 147-165.
112. Lin L-H, Chen L, Harris RA. Enflurane inhibits NMDA, AMPA and KA-induced currents in Xenopus oocytes expressing mouse and human brain mRNA. FASEB Journal 1993; 7: 479-485.
113. Lipton SA. Prospects for clinically tolerated NMDA antagonists: open channel blockers and alternative redox states of nitric oxide. Trends in Neurosciences 1993; 16: 527-532.
114. Lipton SA, Choi Y-B, Pan ZH, Lei SZ, Chen H-SV, Sucher NJ, Loscalzo J, Singel DJ, Stamer JS. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature (London) 1993; 364: 626-632.
115. Little HJ. How has molecular pharmacology contributed to our understanding of the mechanism(s) of general anaesthesia? Pharmacology and Therapeutics 1996; 69: 37-58.
116. Liu D, Thangnipon W, McAdoo DJ. Excitatory amino acids rise to toxic levels upon impact injury ro the rat spinal cord. Brain Research 1991; 547: 344-348.
117. Lucas JH, Wolf A. In vitro studies of multiple impact injury in mammalian neurones: prevention of perikaryal damage by ketamine. Brain Research 1991; 543: 181-193.
118. Lynch DR, Dawson TM. Secondary mechanisms in neuronal trauma. Current Opinion in Neurology 1994; 7: 510-516.
119. 2+-concentrations in cultured spinal cord neurones. Nature (London) 1986; 321: 519-522.
120. McFarlane C, Warner DS, Todd MM, Nordholm L. AMPA receptor competitive antagonism reduces halothane MAC in rats. Anesthesiology 1992; 77: 1165-1170.
121. McFarlane C, Warner DS, Nader A, Dexter F. Glycine receptor antagonism: effects of ACEA-1021 on the minimum alveolar concentration for halothane in the rat. Anesthesiology 1995; 82: 963-968.
122. McIntosh TK, Smith DH, Garde E. Therapeutic approaches for the prevention of secondary brain injury. European Journal of Anaesthesiology 1996; 13: 291-309.
123. MacIver MB, Amagasu SM, Mikulec AA, Monroe FA. Riluzole anesthesia: use dependent block of presynaptic glutamate fibers. Anesthesiology 1996; 85: 626-634.
124. MacIver MB, Mikulec AA, Amagasu SM, Monroe FA. Volatile anesthetics depress glutamate transmission via presynaptic actions. Anesthesiology 1996; 85: 823-834.
125. MacIver MB, Roth SH. Barbiturate effects on hippocampal excitatory responses are selective and pathway specific. Canadian Journal of Physiology and Pharmacology 1987; 65: 385-394.
126. MacIver MB, Tauck DL, Kendig JJ. General anaesthetic modification of synaptic facilitation and long-term potentiation in hippocampus. British Journal of Anaesthesia 1989; 62: 301-310.
127. McQuay HJ, Carroll D, Jajad AR, Glynn CJ, Lack T, Moore RA, Wiffen PJ. Dextromethorphan for the treatment of neuropathic pain: a double blind randomised crossover trial with integral n-of-1 design. Pain 1994; 59: 127-133.
128. Malandro MS, Kilberg MS. Molecular biology of mammalian amino acid transporters. Annual Review of Biochemistry 1996; 65: 305-336.
129. Malinovsky J-M, Cozian A, Lepage J-Y, Mussini J-M, Pinaud M, Souron R. Ketamine and midazolam neurotoxicity in the rabbit. Anesthesiology 1991; 75: 91-97.
130. Mantz J-M, Cheramy A, Thierry AM, Glowinski J, Desmonts JM. Anesthetic properties of riluzole (54274 RP), a new inhibitor of glutamate transmission. Anesthesiology 1992; 76: 844-848.
131. Martin DC, Plagenhoef M, Abraham J, Dennison RL, Aronstam RS. Volatile anaesthetics and glutamate activation of N-methyl-D-aspartate receptors. Biochemical Pharmacology 1995; 49: 809-817.
132. Mayer M, Vylicky L jr, Westbrook GL. Modulation of excitatory amino acid receptors by group IIb metal cations in cultured mouse hippocampal neurones. Journal of Physiology (London) 1989; 415: 329-350.
133. 2+ of NMDA responses in spinal cord neurones. Nature (London) 1984; 309: 261-263.
134. Mayer ML, Westbrook GL, Vylicky L jr. Sites of action on N-methyl-D-aspartic acid receptors studied using fluctuation analysis and a rapid perfusion technique. Journal of Neurophysiology 1988; 60: 645-663.
135. Meldrum BS, Chapman AG. Competitive NMDA antagonists as drugs. In: Collingridge GL, Watkins JC, eds. The NMDA Receptor, 2nd Edn. Oxford: Oxford University Press, 1994; 457-468.
136. Mercadante S. Ketamine in cancer pain: an update. Palliative Medicine 1996; 10: 225-230.
137. Merzenich MM, Sameshima K. Cortical plasticity and memory. Current Opinion in Neurobiology 1993; 3: 187-196.
138. 2+ transients and glutamate release in isolated cerebral synaptosomes. Anesthesiology 1995; 83: 593-603.
139. Miller RJ. G-protein linked glutamate receptor. Seminars in the Neurosciences 1994; 6: 105-115.
140. Minchin MCW. The effect of anaesthetics on the uptake and release of γ-aminobutyrate and D-aspartate in rat brain slices. British Journal of Pharmacology 1981; 73: 681-689.
141. Monasky MS, Zinsmeister AR, Stevens CW, Yaksh TL. Interaction of intrathecal morphine and ST-91 on antinociception in the rat: dose-response analysis, antagonism and clearance. Journal of Pharmacology and Experimental Therapeutics 1990; 254: 383-392.
142. Morris RGM, Davis M. The role of NMDA receptors in learning and memory. In: Collingridge GL, Watkins JC, eds. The NMDA Receptor, 2nd Edn. Oxford: Oxford University Press, 1994; 340-375.
143. Munglani R, Andrade J, Sapsford DJ, Baddeley J, Jones JG. A measure of consciousness and memory during isoflurane administration: the coherent frequency. British Journal of Anaesthesia 1993; 71: 633-641.
144. Munglani R, Fleming BG, Hunt SP. Remembrance of times past: the significance of c-fos in pain. British Journal of Anaesthesia 1996; 76: 1-4.
145. Naguib M, Adu-Gyamfi Y, Absood GH, Farag H, Gyasi HK. Epidural ketamine for postoperative analgesia. Canadian Anaesthetists Society Journal 1986; 33: 16-21.
146. Nakakimura K, Sakabe T, Funatsu N, Maekawa T, Takeshita H. Metabolic activation of intercortical and corticothalamic pathways during enflurane anesthesia in rats. Anesthesiology 1988; 68: 777-782.
147. Nakashima K, Todd MM. Effects of hypothermia, pentobarbital, and isoflurane on postdepolarization amino acid release during complete global cerebral ischemia. Anesthesiology 1996; 85: 161-168.
148. Narimatsu E, Tsai Y-C, Gerhold TD, Kamath SH, Davies LR, Sokoll MD. A comparison of the effect of halothane on N-methyl-D-aspartate receptor-mediated excitatory synaptic transmission in the hippocampus. Anesthesia and Analgesia 1996; 82: 843-847.
149. Nichol B, Rowbotham DJ, Lambert DG. Glutamate uptake is not a major target site for anaesthetic agents. British Journal of Anaesthesia 1995; 75: 61-65.
150. Nicoletti F, Bruni V, Copani A Casabona G, Knopfel T. Metabotropic glutamate receptors: a new target for therapy of neurodegenerative disorders? Trends in Neurosciences 1996; 19: 267-271.
151. Nikolajsen L, Hansen CL, Nielsen J, Keller J, Arendt-Nielsen L, Jensen TS. The effect of ketamine on phantom pain: a central neuropathic disorder maintained by peripheral input. Pain 1996; 67: 69-77.
152. Nowak L, Bregestovski P, Ascher P, Herbet A, Proschiantz A. Magnesium gates glutamate activated channels in mouse central neurones. Nature (London) 1984; 307: 462-165.
153. O'Connor TC, Abram SE. Inhibition of nociception-induced spinal sensitization by anesthetic agents. Anesthesiology 1995; 82: 259-266.
154. Olney JW, Labruyere J, Price MT. Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science 1989; 244: 1360-1362.
155. Olney JW, Labruyere J, Wang G, Wozniak DF, Price MT, Sesma MA. NMDA antagonist neurotoxixity: mechanism and prevention. Science 1991; 254: 1515-1518.
156. Olsen UB, Lund A .Inhibition by glutamate antagonists, MK-801 and NBQX, of cutaneo-cardiovascular pain reflex in rats. European Journal of Pharmacology 1991; 203: 133-135.
157. Ori C, Dam M, Pizzoiato G, Battistin L, Giron G. Effects of isoflurane anesthesia on local glucose utilization in the rat. Anesthesiology 1986; 65: 152-156.
158. Ossipov MH, Harris S, Lloyd P, Messineo E, Lin BS, Bagley J. Antinociceptive interactions between opioids and medetomidine: systemic additivity and spinal synergy. Anesthesiology 1990; 73: 1227-1235.
159. Ossipov MH, Lozito R, Messineo E, Green J, Harris S, Lloyd P. Spinal antinociceptive synergy between clonidine and morphine, U69593 and DPDPE: isobolographic analysis. Life Sciences 1990; 47: 71-76.
160. Patel PM, Drummond JC, Cole DJ, Goskowicz RL. Isoflurane reduces ischemia-induced glutamate release in rats subjected to forebrain ischemia. Anesthesiology 1995; 82: 996-1003.
161. Pearce RA, Stringer JL, Lothman EW. Effect of volatile anesthetics on svnaptic transmission in the rat hippocampus. Anesthesiology 1989; 71: 591-598.
162. Perouansky M, Baranov D, Salman M, Yaari Y. Effects of halothane on glutamate receptor-mediated excitatory postsynaptic currents. Anesthesiology 1995; 83: 109-119.
163. Pin JP, Duvoisin R. Review: Neurotransmitter receptors I. The metabotropic glutamate receptors: structure and functions. Neuropharmacology 1995; 34: 1-26.
164. Pines G, Danbolt NC, Bjoras M, Zhang Y, Bendahan A, Eide L, Koepsell H, Storm-Mathisen J, Seeburg E, Kanner BI. Cloning and expression of a rat L-glutamate transporter. Nature (London) 1992; 360: 464-467.
165. Pockett S. Long-term potentiation and long-term depression in the intermediate grey region of the spinal cord in vitro. Neuroscience 1995; 67: 791-798.
166. Pocock G, Richards CD. Excitatory and inhibitory synaptic mechanisms in anaesthesia. British Journal of Anaesthesia 1993; 71: 134-147.
167. Pratt J, Rataud J, Bardot F, Roux M, Blanchard JC, Laduron PM. Neuroprotective effects of riluzole in rodent models of global and focal cerebral ischaemia. Neuroscience Letters 1992; 140: 225-230.
168. Puil E, El-Beheiry H. Anaesthetic supression of transmitter actions in neorcortex. British Journal of Pharmacology 1990; 101: 61-66.
169. Puil E, El-Beheiry H, Baimbridge KG. Anesthetic effects on glutamate-stimulated increase in intraneuronal calcium. Journal of Pharmacology and Experimental Therapeutics 1990; 255:955-961.
170. Rampil IJ. Anesthetic potency is not altered after hypothermic spinal cord transection in rats. Anesthesiology 1994; 80: 606-610.
171. Rampil IJ, Mason P, Singh H. Anesthetic potency (MAC) is independent of forebrain structures in the rat. Anesthesiology 1993; 78: 707-712.
172. Randic M, Jiang MC, Cerne R. Long term potentiation and long term depression of primary afferent neurotransmission in the rat spinal cord. Journal of Neuroscience 1993; 13: 5228-5441.
173. Ravat F, Dorne R, Baechle JP, Beaulaton A, Lenoir B, Leroy P, Palmier B. Epidural ketamine or morphine for postoperative analgesia. Anesthesiology 1987; 66: 819-822.
174. Reidel G, Seidenbecher T, Reyman KG. LTP in hippocampal CA1 of urethane-narcotized rats requires stronger tetanization parameters. Physiology and Behavior 1994; 55: 1141-1146.
175. Reynolds ZJ. Arcaine uncovers dual interactions of polyamines with the N-methyl-D-aspartate receptor. Journal of Pharmacology and Experimental Therapeutics 1990; 255: 1001-1007.
176. Richards CD. The synaptic basis of general anaesthesia. European Journal of Anaesthesiology 1995; 12: 5-19.
177. Richards CD, Russell WJ, Smaje JC. The action of ether and methoxyflurane on synaptic transmission in isolated preparations of the mammalian cortex. Journal of Physiology (London) 1975; 248: 121-142.
178. Richards CD, Smaje JC. Anaesthetics depress the sensitivity of cortical neurones to L-glutamate. British Journal of Pharmacology 1976; 58: 347-357.
179. Richards CD, White AE. The actions of volatile anaesthetics on synaptic transmission in the dentate gyrus. Journal of Physiology (London) 1975; 252: 241-257.
180. Rogawski MA. Therapeutic potential of excitatory amino acid antagonists: channel blockers and 2,3 benzodizepines. Trends in Pharmacological Sciences 1993; 14: 325-331.
181. Roskies AL. Mapping memory with positron emission tomography. Proceedings of the National Academy of Sciences USA 1994; 91: 1989-1991.
182. Rothstein JD, Martin L, Levey AI, Dykes Hoberg M, Jin L, Wu D, Nash N, Kuncl RW. Localization of neuronal and glial glutamate transporters. Neuron 1994; 13: 713-725.
183. Roytblat L, Korotkorutchko A, Katz J, Glazer M, Greemberg L, Fisher A. Post-operative pain: the effect of low dose ketamine in addition to general anesthesia. Anesthesia and Analgesia 1993; 77: 1161-1165.
184. Rusin KI, Randic M. Modulation of NMDA-induced currents by μ-opioid receptor agonist DAGO in acutely isolated spinal cord dorsal horn neurons. Neuroscience Letters 1991; 124: 208-212.
185. Sanchez-Capuchino A, McConachie I. Peri-operative effect of major gastro-intestinal surgery on serum magnesium. Anaesthesia 1994; 49: 912-914.
186. Savola MKT, Woodley SJ, Kendig JJ. Isoflurane depresses both glutamate and peptide-mediated slow synaptic transmission in neonatal rat spinal cord. Annals of the New York Academy of Sciences 1991; 625: 281-282.
187. 2-adrenoceptor agonist supress nociceptive transmission in neonatal rat spinal cord. Anesthesiology 1991; 75: 489-498.
188. Sawada S, Yamamoto C. Blocking action of pentobarbital on receptors for excitatory amino acids in the guinea pig hippocampus. Experimental Brain Research 1985; 59: 226-231.
189. Scheller MS, Zornow MH, Fleischer JE. The non-competitive N-methyl-D-aspartate receptor antagonist MK-801 potently reduces volatile anaesthetic requirement in rabbits. Neuropharmacology 1989; 28: 677-681.
190. Schlame M, Hemmings HC. Inhibition by volatile anesthetics of endogenous glutamate release from synaptosomes by a presynaptic mechanism. Anesthesiology 1995; 82: 1406-1416.
191. Schoepp DD, Conn PJ. Metabotropic glutamate receptors in brain function and pathology. Trends in Pharmacological Sciences 1993; 14: 13-20.
192. Schwender D, Klasing S, Madler C, Poppel E, Peter K. Mid-latency auditory evoked potentials during ketamine anaesthesia in humans. British Journal of Anaesthesia 1993; 71: 629-632.
193. Seeburg PH. The molecular biology of glutamate receptor channels. Trends in Pharmacological Sciences 1993; 14: 297-303.
194. 3H]MK-801 binding sites in the normal human spinal cord. Brain Research 1991; 539: 164-168.
195. Simpson JI, Eide TR, Schiff GA, Clagnaz JF, Hossain I, Tverskoy A, Koski G. Intrathecal magnesium sulfate protects the spinal cord from ischaemic injury during thoracic aortic cross clamping. Anesthesiology 1994; 81: 1493-1499.
196. Smith SE, Meldrum BS. Cerebroprotective effect of lamotrigine after focal cerebral ischemia in rats. Stroke 1995; 26: 117-122.
197. Sommer B, Keinanen K, Verdoorn TA, Wisden W, Burnashev N, Herb A, Kohler M, Takagi T, Sakman B, Seeburg P. Flip and flop: a cell-specific functional switch in glutamate-operated channels iof the CNS. Science 1990; 249: 1580-1585.
198. Squire LR, Alvarez P. Retrograde amnesia and memory consolidation: a neurobiological perspective. Current Opinion in Neurobiology 1995; 5: 169-177.
199. Squire LR, Zola-Morgan S. The medial temporal lobe memory system. Science 1991; 253: 1380-1386.
200. Stannard CF, Porter GE. Ketamine hydrochloride in the treatment of phantom limb pain. Pain 1993; 94: 227-230.
201. +-dependent glutamate/aspartate transporter from rat brain. Proceedings of the National Academy of Sciences USA 1992; 89: 10955-10959.
202. Study RE. Isoflurane inhibits multiple voltage-gated calcium currents in hippocampal pyramidal neurones. Anesthesiology 1994; 81: 104-116.
203. Sucher N, Awobuluyi M, Choi Y-B, Lipton SA. NMDA receptors: from genes to channels. Trends in Pharmacological Sciences 1996; 17: 348-355.
204. Sukiennik AW, Kream RM. N-methyl-D-aspartate receptors and pain. Current Opinion in Anesthesiology 1995; 8: 445-449.
205. Sun WZ, Shyu BC, Shieh JY. Nitrous oxide or halothane, or both, fail to suppress c-fos expression in rat spinal cord dorsal horn neurones after subcutaneous formalin. British Journal of Anaesthesia 1996; 76: 99-105.
206. Tolle T, Berthele A, Zieglandsberger W, Seeburg PH, Wisden W. The differential expression of 16 NMDA and non-NMDA receptor subunits in the rat spinal cord and periaqueductal gray. Journal of Neuroscience 1993; 13: 5009-5028.
207. Tramer MR, Schneider J, Marti R-A, Rifat K. Role of magnesium sulfate in postoperative analgesia. Anesthesiology 1996; 84: 340-347.
208. Tulving E, Kapur S, Craik FIM, Moscovitch M, Houle S. Hemispheric encoding/retrieval asymetry in episodic memory: positron emission tomography findings. Proceedings of the National Academy of Sciences USA 1994; 91: 2016-2020.
209. Tverskoy M, Oz Y, Isakson A, Finger J, Bradley EL jr, Kissin I. Pre-emptive effect of fentanyl and ketamine on post-operative pain and wound hyperalgesia. Anesthesia and Analgesia 1994; 78: 205-209.
210. Ungerleide LG. Functional brain imaging studies of cortical mechanisms for memory. Science 1995; 270: 769-775.
211. Upton N. Mechanism of actions of new anti-epileptic drugs: rational design and serendipitous findings. Trends in Pharmacological Sciences 1994; 15: 456-463.
212. Urban L, Thompson SWN, Dray A. Modulation of spinal excitability: co-operation between neurokinin and excitatory amino acid neurotransmitters. Trends in Neurosciences 1994; 17: 432-438.
213. 2+ protect against irreversible damage during CNS ischemia. Stroke 1984; 15: 695-698.
214. Warner DS. Mild hypothermia as a clinical strategy for neuroprotection. Current Opinion in Anesthesiology 1995; 8: 396-400.
215. Warner DS, Deshpande JK, Wieloch T. The effect of isoflurane on neuronal necrosis following near complete forebrain ischaemia in the rat. Anesthesiology 1986; 64: 19-23.
216. Wasterlain CG, Adams LM, Hattori H, Schwanz PH. Felbamate reduces hypoxic/ischaemic brain damage in vivo. European Journal of Pharmacology 1992; 212: 275-278.
217. Wee MYK, Hasan MA, Thomas TA. Isoflurane in labour. Anaesthesia 1993; 48: 369-372.
218. Weight FF, Lovinger DM, White G, Peoples RW. Alcohol and anesthetic actions on excitatory amino acid-activated ion-channels. Annals of the New York Academy of Sciences 1991; 625: 97-107.
219. Weiskrantz L. Problems of learning and memory: one or multiple memory systems. Philosophical Transactions of the Royal Society of London B 1990; 329: 99-108.
220. 2+ antagonize NMDA and GABA responses of hippocampal neurones. Nature (London) 1987; 328: 640-643.
221. Wheeler-Aceto H, Porreca F, Cowam A. The rat paw formalin test: comparison of noxious agents. Pain 1990; 40: 229-238.
222. Wiard RP, Dickerson MC, Beek O, Norton R, Cooper BR. Neuroprotective properties of the novel antiepileptic lamotrigine in a gerbil model of global cerebral ischaemia. Stroke 1995; 26: 466-472.
223. Wisden W, Seeburg PH. Mammalian ionotropic glutamate receptors. Current Opinion in Neurobiology 1993; 3: 291-298.
224. Woolf CJ. Windup and central sensitization are not equivalent. Pain 1996; 66: 105-108.
225. Woolf CJ, Chong MS. Preemptive analgesia-treating postoperative pain by preventing the establishment of central sensitization. Anesthesia and Analgesia 1993; 77: 362-379.
226. Xu XJ, Hao JX, Seiger A, Wiesenfeld-Hallin Z. Systemic excitatory amino acid antagonists of the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) receptor and of the N-methyl-D-aspartate (NMDA) receptor relieve mechanical hypersensitivity after transient spinal cord ischaemia in rats. Journal of Pharmacology and Experimental Therapeutics 1993; 267: 140-144.
227. Yaksh TL, Malmberg AB. Central pharmacology of nociceptive transmission. In: Wall PD, Melzack R, eds. Textbook of Pain, 2nd Edn. London: Churchill Livingstone, 1994; 165-200.
228. Yamamoto T, Yaksh TL. Comparison of the antinociceptive effects of pre- and posttreatment with intrathecal morphine and MK-801, on the formalin test in the rat. Anesthesiology 1992; 77: 757-763.
229. Yang J, Zorumski CF. Effects of isoflurane on N-methyl-D-aspartate gated ion channels in cultured rat hippocampal neurones. Annals of the New York Academy of Sciences 1991; 625: 287-289.
230. 3H-phorbol 12,13-dibutyrate binding in spinal cord dorsal horn as well as persistent pain and hyperalgesia, which is reduced by inhibition of protein kinase C. Journal of Neuroscience 1995; 15: 3263-3272.
231. Young AB, Fagg GE. Excitatory amino acid receptors in the brain: membrane binding and receptor autoradiographic approaches. Trends in Pharmacological Sciences 1990; 11: 126-133.
232. Zukin R, Bennett MVL. Alternatively spliced isoforms of the NMDAR1 receptor subunit. Trends in Neurosciences 1995; 18: 306-313.